Javier De Castro-Carpeño

24PUBLICATIONS

207CO-AUTHORS

Molecular targetsPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Tumour immunology

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (24)

Sort by Publication Date:

|Jul 13, 2026

Osimertinib Plus Gefitinib in Patients with EGFR-Mutated Advanced Non-Small Cell Lung Cancer and EGFR (C797X) Mutation Following First-Line Osimertinib: ORCHARD.

|Apr 13, 2026

Second Line Treatment Decision as Per Standard of Care or Foundation Medicine in Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer.

Federico Rojo, Enriqueta Felip, Oscar Juan Vidal

|Mar 10, 2026

Decoding B-cell Signatures of Complete Pathologic Response to Perioperative Chemoimmunotherapy in Non-Small Cell Lung Cancer.

Belén Sierra-Rodero, Ángeles Gil-González, Marta Molina-Alejandre

|Mar 06, 2026

ELIOS: A Multicenter, Molecular Profiling Study of Patients with EGFR-Mutant Advanced Non-Small Cell Lung Cancer Treated with First-Line Osimertinib.

Zofia Piotrowska, Myung-Ju Ahn, Pei Jye Voon

|Mar 04, 2026

Unveiling miR-451a and miR-142-3p as prognostic markers in non-small cell lung cancer via small extracellular vesicle liquid biopsy.

Miranda Burdiel, Ana Arauzo-Cabrera, Julia Jiménez

|Jan 15, 2026

Minimal Residual Disease Enhances Prognostic Stratification beyond Pathologic Response in Resectable Non-Small Cell Lung Cancer.

Mariano Provencio, Roberto Serna-Blasco, Ernest Nadal

Pageof 4

Frequent Collaborators

8 joint publications

Ernest Nadal

8 joint publications

Mariano Provencio Pulla

6 joint publications

Alberto Cruz-Bermúdez

Amelia Insa Molla

Alex Martínez-Martí

Manuel Cobo

Bartomeu Massutí

Manuel Dómine

Delvys Rodríguez-Abreu

5 joint publications

Virginia Calvo

Frequent Collaborators

8 joint publications

Ernest Nadal

8 joint publications

Mariano Provencio Pulla

6 joint publications

Alberto Cruz-Bermúdez

6 joint publications

Amelia Insa Molla